Palatin Technologies Inc. buy stratec
Start price
08.11.17
/
50%
€17.38
Target price
28.10.19
€35.00
Performance (%)
10.07%
End price
28.10.19
€19.13
Summary
This prediction ended on 28.10.19 with a price of €19.13. The prediction had a final performance of 10.07%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Palatin Technologies Inc. | -2.417% | -2.417% | -18.462% | -87.575% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
Comments by stratec for this prediction
In the thread Palatin Technologies diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 08.11.2017 der Buy-Einschätzung von tamam mit dem Kursziel 0,8€ zu.
Überschrift: tamam stimmt der Buy-Einschätzung von datca zu
- The FDA has extended its action date for its review of Palatin Technologies' (NYSEMKT:PTN) Vyleesi (bremelanotide) for hypoactive sexual desire disorder in postmenopausal women to June 23.
- FDA approval will trigger a $60M milestone payment from licensor AMAG Pharmaceuticals (NASDAQ:AMAG).
Stopped prediction by stratec for Palatin Technologies Inc.
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€17.63
11.11.19
11.11.19
€50.00
04.11.21
04.11.21
-49.08%
05.11.21
05.11.21
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€19.13
28.10.19
28.10.19
-
11.11.19
11.11.19
-7.84%
11.11.19
11.11.19